3 Hrs
Source:
وكالة الانباء العراقية (واع)
وكالة الانباء العراقية (واع)
Ready to play
Ready to play
Scientists from Perm State Technical University in Russia have developed a method that allows the use of biologically active "Calcon" compounds in drug manufacturing, despite their sensitivity to heat treatment. These compounds are considered a preferred option due to their low toxicity and cost, but the challenge has been their inability to withstand traditional thermal manufacturing processes. This new solution opens up broader possibilities for the pharmaceutical industry to benefit from the advantages of "Calcon," which could help reduce costs and enhance the safety of pharmaceutical products.
Notice: This Is an AI-Generated Summary
Comments (0)